Targeted Medical Pharma Combats the Epidemic of Pain with Release of THERALEVE™

LOS ANGELES–(BUSINESS WIRE)–Targeted
Medical Pharma
, Inc. (OTCQB: TRGM) in conjunction with Amino
Nutritionals LLC, today announced the consumer release of THERALEVE
(www.theralevehealth.com)
a patented amino acid based formula designed by pain management
physicians to help the 100 million chronic pain sufferers in the United
States, fight pain and inflammation without the dangerous side effects
commonly associated with NSAIDs and opioids.

“Common pain medications do not address the nutritional needs of the
nervous system and only target symptoms of pain. THERALEVE
provides a specific blend of amino acids and nutrients that support the
foundation of good health and address the underlying factors that cause
pain,” said Dr.
David Silver
, Chief Medical Officer at Targeted Medical Pharma.

THERALEVE is the first dietary supplement specifically designed
to support the nervous system health of chronic pain sufferers.
Previously only available through physicians, the patented amino acid
formula in THERALEVE has been recommended to chronic pain
sufferers by physicians for over a decade, with over 26 million doses
taken and no reported dangerous side effects.

THERALEVE is the only amino acid based dietary supplement to use Targeted
Cellular Technology
, a patented micro-nutrient delivery system that
aids the absorption of the key ingredients required to revitalize
nervous system function and support the natural anti-inflammatory and
pain fighting processes of the body. THERALEVE supports healthy
joint, muscle and nervous system function in the fight against pain and
inflammation.*

Follow THERALEVE on Facebook
at: www.facebook.com/theraleve
and on Twitter:
www.twitter.com/theraleve.

About Targeted Medical Pharma, Inc.

Targeted
Medical Pharma, Inc.
(OTCQB:TRGM) is a Los Angeles based
biotechnology company that develops and manufactures amino acid based
medical foods and dietary supplements featuring the patented Targeted
Cellular Technology
. The Company distributes these products to
physicians, pharmacies, hospitals, patients, and consumers throughout
the United States, Japan and China to effectively treat pain, obesity,
hypertension, sleep and cognitive disorders without the serious side
effects associated with many drug therapies.

*These statements have not been evaluated by the FDA. This
product is not intended to diagnose, treat, cure or prevent any disease.

Contacts

Targeted Medical Pharma, Inc.
Media Contacts:
Marcus
Charuvastra, (844) 474-3111
marcusch@tmedpharma.com
or
Investor
Contacts:

William B. Horne, (310) 474-9809
whorne@tmedpharma.com